Observational study / 2019
Buchinger periodic fasting for 4 to 21 days was linked to improvements in weight, blood pressure, metabolic markers, and well-being with low adverse effects.
In a 1-year observational study, 1,422 subjects participated in a specialized clinic program consisting of Buchinger periodic fasting (200-250 kcal daily) for 4 to 21 days, grouped into durations of 5, 10, 15, and 20±2 days. Significant reductions in weight, abdominal circumference, and blood pressure were observed across the entire cohort (each p<0.001), alongside decreased blood glucose and increased ketone bodies (each p<0.001). Physical and emotional well-being increased (p<0.001), 93.2% reported an absence of hunger feelings, and 84.4% of 404 subjects with pre-existing complaints reported improvement. Adverse effects were reported in less than 1% of participants.
Shows an association, not proof of cause and effect.
- Study type
- Prospective observational study
- Who was studied
- 1,422 subjects participating in a periodic fasting program
- What was measured
- Safety, adverse effects, body weight, abdominal circumference, blood pressure, blood lipids, glucose, ketone bodies, and well-being
THE PAPER
Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects.
Wilhelmi de Toledo F, Grundler F, Bergouignan A, Drinda S, Michalsen A. PLoS One, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.